Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
Japan flag Japan · Delayed Price · Currency is JPY
121.00
-14.00 (-10.37%)
At close: Mar 6, 2026

TYO:4596 Income Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
21.3427398-
Revenue Growth (YoY)
-20.98%-30.77%387.50%--
Cost of Revenue
336.685125-
Gross Profit
-315.3522273-
Selling, General & Admin
542.99711633602604
Research & Development
-5437881,5122,040
Other Operating Expenses
36.521110--
Operating Expenses
579.511,2551,5312,1142,644
Operating Income
-894.86-1,233-1,504-2,111-2,644
Interest Expense
-0.87-7-9-11-18
Interest & Investment Income
1.855131811
Other Non Operating Income (Expenses)
-0.2515118935
EBT Excluding Unusual Items
-894.13-1,220-1,489-2,015-2,616
Gain (Loss) on Sale of Assets
--56---
Asset Writedown
--56---
Other Unusual Items
217.87----
Pretax Income
-676.25-1,332-1,489-2,015-2,616
Net Income
-676.25-1,332-1,489-2,015-2,616
Net Income to Common
-676.25-1,332-1,489-2,015-2,616
Shares Outstanding (Basic)
6456564946
Shares Outstanding (Diluted)
6456564946
Shares Change (YoY)
13.32%1.35%12.85%8.19%6.30%
EPS (Basic)
-10.59-23.64-26.78-40.90-57.45
EPS (Diluted)
-10.59-23.65-26.79-40.92-57.46
Free Cash Flow
-593.63-1,244-1,401-2,143-2,521
Free Cash Flow Per Share
-9.30-22.08-25.20-43.50-55.36
Gross Margin
-81.48%69.23%37.50%-
Operating Margin
-4194.31%-4566.67%-3856.41%-26387.50%-
Profit Margin
-3169.69%-4933.33%-3817.95%-25187.50%-
Free Cash Flow Margin
-2782.43%-4607.41%-3592.31%-26787.50%-
EBITDA
-829.21-1,168-1,417-2,053-2,585
D&A For EBITDA
65.6565875859
EBIT
-894.86-1,233-1,504-2,111-2,644
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.